A 302-pound loggerhead sea turtle hit by a boat gets an oversize CT scan, with a surprise
JUNO BEACH, Fla. (AP) — A massive loggerhead sea turtle hit by a boat off Florida's Atlantic coast arrived at a turtle hospital needing medical care, but at 302 pounds (137 kilograms), Pennywise was too large to fit their equipment.
So the veterinary team at the Loggerhead Marinelife Center in Juno Beach took her to nearby Jupiter Medical Center, hoping she could get a CT scan on a human machine. She was too big for that, as well.
They quickly came up with another plan: taking Pennywise to Palm Beach Equine Clinic in Wellington, where the scan was performed on equipment designed for horses.
'And, luckily, the horse-sized machine was big enough to fit this lady through," Heather Barron, the chief science officer and veterinarian at Loggerhead, told The Associated Press.
Turns out, they also got a nice surprise: Images showed that Pennywise is carrying eggs.
'We hope we'll be able to get her back out there into the wild as soon as possible so that she can lay those eggs," Barron said.
Loggerheads, an endangered species, often lay multiple clutches during a season, she said.
Pennywise arrived at the center Monday, after a crew from Inwater Research Group found her floating in the Atlantic with significant blunt force trauma to her shell that had already started to heal.
The staff at the Juno Beach turtle center estimated that Pennywise's injuries were about a month old. Barron said the imaging showed some damage to bones that surround the spinal cord. They have the turtle on high-powered antibiotics.
"Luckily, right now, her neurologic exam shows that all those nerves are intact. And that is a great sign for her. We're very excited about that and we'll just be rechecking to make sure that we have no progression of the disease, and as soon as we feel like that wound is healed well enough, she can go back out into the wild.'
Even so, Barron said, Pennywise's story is a 'textbook case of a turtle returning to the area for mating and nesting season, only to fall victim to an entirely preventable boat-strike injury.'
Because nesting season in Florida runs from March 1 to Oct. 31, officials at the sea turtle center are encouraging boaters to slow down and to be especially mindful in what they refer to as the Sea Turtle Protection Zone, which extends a mile (1.6 kilometers) off the coast.
___
Frisaro reported from Fort Lauderdale, Florida.
Cody Jackson And Freida Frisaro, The Associated Press
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
06/06/2025, Miami, Florida // PRODIGY: Feature Story // Anna Forsythe, founder of Oncoscope-AI (source: Oncoscope-AI) Oncoscope-AI, a revolutionary oncology intelligence platform, has officially launched following a successful beta phase and over a year of strategic development that involved extensive conversations with practicing oncologists. The platform, which delivers real-time, human-curated cancer insights enhanced by artificial intelligence, is now live and available free of charge to verified healthcare professionals worldwide. Founded by Anna Forsythe, a pharmacist, health economist, and seasoned pharmaceutical executive, Oncoscope addresses a critical gap in oncology care. It gives clinicians instant access to the most current treatment data, FDA approvals, and guideline-aligned information, consolidated into one user-friendly platform. 'Doctors do not need more data. They need the right information, at the right time, in a format they can use to make better decisions for their patients,' said Forsythe. 'Oncoscope provides that clarity. It is a living library of oncology, curated by experts and built to save lives.' Unlike generic AI tools or static databases, Oncoscope uses trained AI to scan thousands of oncology publications and filters them through a rigorous, evidence-based framework. Each entry is cross-referenced with clinical guidelines and regulatory approvals to ensure usability and relevance. All of the results are carefully scrutinized by a team of experienced researchers. Currently, the platform supports breast and lung cancer, with prostate, bladder, colon, and rectal modules rolling out in the coming months. The process is intuitive. Physicians answer three clinical questions—cancer stage, genetic markers, and prior treatments—and receive a personalized, actionable summary. Each recommended article includes survival data, progression insights, treatment efficacy, and toxicity, extracted across 32 key clinical parameters. 'The result is something physicians can actually use in the moment,' said Forsythe. 'It takes three clicks to go from a patient in the room to the most up-to-date evidence in the field.' Access to Oncoscope is free for verified healthcare professionals, including physicians, nurses, pharmacists, genetic counselors, and physician assistants. Non-verified users, such as those in finance or consulting, can purchase limited access at a monthly rate, restricted to a single cancer type. This structure reflects the company's commitment to empowering front-line clinicians with better tools—without barriers. Forsythe, who previously founded and sold a successful health economics company serving global pharmaceutical clients, brings a rare combination of clinical, technical, and business expertise to this venture. She sees Oncoscope not only as a tool, but as a mission. 'This platform was born from both professional insight and personal urgency,' she said. 'Too many patients are still receiving outdated treatments, simply because their doctors do not have time to stay current. I realized I had the knowledge, the team, and the experience to fix that.' With a lean team, strategic vision, and a rapidly growing user base, Oncoscope is poised to become a trusted global resource in cancer treatment. 'We are not just a tech company,' said Forsythe. 'We are part of the oncology ecosystem. And we are here to help doctors deliver the best care possible.' For more information, visit Media Contact: Name - Anna Forsythe Email - [email protected] Source published by Submit Press Release >> Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
Yahoo
7 hours ago
- Yahoo
Popular Aldi snack recalled due to potential ‘life-threatening' allergen
Aldi is recalling one of its sweet treats due to the presence of an undeclared allergen. The U.S. Food and Drug Administration (FDA) issued a notice on Tuesday to announce that Camerican International was recalling 7.05 oz boxes of Casa Mamita Churro Bites Filled with Chocolate Hazelnut Cream. The recall was issued because the Aldi brand snack may contain undeclared milk, so consumers with an allergy or 'severe sensitivity to milk run the risk of serious or life-threatening allergic reaction,' per the FDA. The recalled churro bites were distributed at Aldi stores in 13 states: Alabama, Arkansas, Florida, Georgia, Iowa, Illinois, Kentucky, Louisiana, Missouri, Mississippi, North Carolina, South Carolina, and Tennessee. The 7.05 oz cardboard boxes are marked with a 'Best If Used By' date of July 14, 2025, and the Lot Number '01425.' According to the FDA, the recall was initiated after a 'consumer discovered that the milk-containing product was distributed in packaging that did not reveal the presence of milk.' A subsequent investigation revealed the mistake was a result of a 'temporary breakdown in the company's production and packaging processes,' which has since been corrected. However, there have been no illnesses reported to date due to this product. Consumers are now urged to return the churro bites to the place of purchase for a full refund. This isn't the first time Aldi food item to be recalled recently. In May, Santa Monica Seafood of Rancho Dominguez, California, issued a voluntary recall on its Atlantic Salmon Portions with Seafood Stuffing because they may have contained undeclared soy. The affected salmon portions were sold in three states: California, Nevada, and Arizona. The products were sold in 16-ounce packages and had a use/freeze-by date of June 2, 2025. The last two years have also seen an alarming and unexplained rise in recalls. In 2024, approximately 300 food recalls were issued, with those recalls being linked to nearly 1,400 illnesses, a Public Interest Research Group report revealed. Out of the 1,400 illnesses, 487 people became sick enough to require hospitalization, and 19 people died. While those numbers are still low when weighed against the entire U.S. population, they are also double the number of hospitalizations and deaths from food-borne illnesses in 2023. Earlier in May, cucumbers sold across the country were recalled after people in 15 states reported getting ill from salmonella. Florida-based Bedner Growers, Inc. recalled the vegetables distributed by Fresh Start Produce Sales, Inc. from April 29 to May 19.
Yahoo
8 hours ago
- Yahoo
FDA Announces Recall on More Than 19,000 Cases of Dr Pepper for Mislabeling
According to a notice posted by the U.S. Food & Drug Administration (FDA), more than 19,200 12- and 24-pack cases of Dr Pepper Zero Sugar have been recalled. The recall was initiated after the soda, which is labeled as 'zero sugar,' was found to contain full sugar. The recalled cases of Dr Pepper Zero Sugar were produced by Jacksonville, Florida-based Pepsi Beverages Company, which is licensed to manufacture Keurig Dr Pepper-owned products including Dr Pepper. The soda was distributed to retailers in three states: Florida, Georgia, and South Carolina. To identify if you have the recalled Dr Pepper, you should check for the following information: 12- or 24-pack carton cases of 12-fluid ounce aluminum cans of Dr Pepper, Zero Sugar Prod Code: XXXXRS05165 "Best By" Date: Feb. 16, 2026 The recall was initiated on May 23, 2025, with the FDA classifying it as a Class II recall—meaning drinking the product could cause 'temporary or medically reversible adverse health consequences'—on June 5, 2025. Because Pepsi Beverages Company initiated the recall at the end of May, it is likely that the products have been pulled from retailer shelves by now; however, you should check to code number just to be sure. No other Dr Pepper Zero Sugar cases or Dr Pepper products are impacted by this recall. If you have the recalled Dr Pepper Zero Sugar and are someone who is monitoring and controlling their sugar intake for medical reasons, it may not be safe to consume the soda. If that's the case, you should throw it away or return it to the original place of purchase for a full refund or replacement. If you are not monitoring your sugar intake, you do not need to do anything regarding this recall. The product was recalled for mislabeling, not because it is inherently harmful to consume. The full-sugar soda just may have a different flavor than anticipated. However, if you do wish to receive the zero-sugar Dr Pepper that you intended to purchase, you can return it to the original place of purchase for a replacement or full refund. Read the original article on ALLRECIPES
